Subscribe
willy-barton
Willy Barton / shutterstock.com
21 May 2020Big PharmaRory O'Neill

Merck KGaA wins injunction after MSD trademark suit

The English High Court has finalised the terms of a trademark injunction against US pharmaceutical company  Merck Sharp & Dohme (MSD), in favour of German rival  Merck KGaA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.

More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.

More features

President Trump 2.0: Five major areas to watch
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court